(1 - 11 von 16
)
Solide Tumoren: Neuer Therapieansatz
www.aerzteblatt.de
... berichtete Prof. Max Scheulen beim Symposium "Neue Aspekte in der Therapie von Leukämien, ...
Folha Online - Reuters - Terapia anticâncer aumenta risco de doença...
www1.folha.uol.com.br
... surgimento de um segundo tumor maligno", disse Max Scheulen, do Centro de Câncer da Alemanha Ocidental, da Universidade de Essen.
CAMPUS:AKTUELL - Newsletter der Universität
www.uni-due.de
„Hierfür bietet das Studiennetzwerk CESAR gute Voraussetzungen“ so Professor Max Scheulen, Präsident der CESAR und Oberarzt am Westdeutschen ...
Side-effects now threaten long-living cancer patientsThe Independent
www.independent.co.uk
— Researchers led by Dr Max Scheulen and Dr Dirk Strumberg of the West German Cancer Centre at the University of Essen, examined 32 patients ... › ...
MOLOGEN AG: Efficacy of MGN1703 DNA cancer medicine far exceeds...
www.eqs-news.com
MOLOGEN AG: Efficacy of MGN1703 DNA cancer medicine far exceeds expectations | MOLOGEN AG | News | Nachricht | Mitteilung
BRIC NEWSibric.org
www.ibric.org
... of suffering a recurrence of their cancer or a second malignancy," said Dr. Max Scheulen of the West German Cancer Center at the University of Essen. › skin › print
History of Changes for Study: NCT ClinicalTrials.gov
clinicaltrials.gov
Contact:Principal Investigator: Max Scheulen, Prof., MD Contact:Sub-Investigator: Bahar Nokay Contact:Sub-Investigator: Heike Richly, MD Contact:Principal Investigator: Max Scheulen, Prof., MD Contact:Sub-Investigator: Bahar Nokay Contact:Sub-Investigator: Heike Richly, MD. Klinikum Esslingen › history
History of Changes for Study: NCT
clinicaltrials.gov
Contact:Principal Investigator: Max Scheulen, Prof., MD Contact:Sub-Investigator: Bahar Nokay Contact:Sub-Investigator: Heike Richly, MD
TRIN Pharma starts phase I clinical trial of TRIN in solid tumors
www.b3cnewswire.com
Appenzell, Switzerland, November 10, b3c newswire / - TRIN Pharma GmbH, specializing in the development of small molecule drugs for tumor treatment,...
M Tacke awarded CESAR prizeUniversity College Dublin
www.ucd.ie
— Dr Max Scheulen, Dr M Tacke, Prof Dr U Jaehde. L-R - Prof. Dr Max E. Scheulen, President of Award and Fellowship Selection Committee (AFSC), ... › news
sortiert nach Relevanz / Datum